ANGIOTENSIN CONVERTING ENZIME GENE I/D POLYMORPHISM AND PROMISSING OF RENOPROTECTIVE AND IMMUNOSUPRESSIVE THERAPY IN CHILDREN WITH NEPHROTIC SYNDROME

ANGIOTENSIN CONVERTING ENZIME GENE I/D POLYMORPHISM AND PROMISSING OF RENOPROTECTIVE AND IMMUNOSUPRESSIVE THERAPY IN CHILDREN WITH NEPHROTIC SYNDROME

To investigate the role of i/d polymorphism gene angiotensin converting enzyme (ACE) in promissing of renoprotective and immunosupressive therapy in children with nephrotic syndrome syndrome (NS) we determined the genotypes of ACE in 76 children with ns including 22 children with chronic renal failu...

Full description

Saved in:

Bibliographic Details
Main Authors:	Zh.P. Sharnova, E.E. Tikhomirov, A.N. Tsygin, V.G. Pinelis
Format:	Article
Language:	Russian
Published:	Union of pediatricians of Russia 2007-08-01
Series:	Педиатрическая фармакология
Online Access:	https://www.pedpharma.ru/jour/article/view/694
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

RENIN ANGIOTENSIN SYSTEM GENE POLYMORPHISMS IN CHILDREN WITH NEPHROTIC SYNDROM
by: Zh.P. Sharnova, et al.
Published: (2006-08-01)

COMMENTS ON THE ARTICLE BY ZH.P. SHARNOVA, YE.YE. TIKHOMIROVA, A.N. TSYGINA, V.G. PINELIS «ANGIOTENSIN CONVERTING ENZIME GENE I/D POLYMORPHISM AND PROMISSING OF RENOPROTECTIVE AND IMMUNOSUPRESSIVE THERAPY IN CHILDREN WITH NEPHROTIC SYNDROME»
by: A.Yu. Asanov
Published: (2007-08-01)

IMMUNOSUPRESSION MINIMIZATION IN KIDNEY TRANSPLANTATION
by: O. N. Reznik, et al.
Published: (2011-12-01)

Role of immunosupression defects in the development of autoimmune diseases
by: S N Bykovskaya, et al.
Published: (2005-08-01)

IMPACT OF ANGIOTENSIN-CONVERTING ENZYME GENE POLYMORPHISM ON THE DEVELOPMENT OF INSULIN RESISTANCE SYNDROME
by: G. E. Roitberg, et al.
Published: (2014-07-01)

Relationship between Angiotensin-Converting Enzyme Insertion/Deletion Gene Polymorphism and Susceptibility of Minimal Change Nephrotic Syndrome: A Meta-Analysis
by: Tian-Biao Zhou, et al.
Published: (2011-01-01)

PHARMACOECONOMIC ANALYSIS OF EVEROLIMUS IMMUNOSUPRESSIVE THERAPY AFTER RENAL TRANSPLANTATION
by: M. V. Avxentyeva, et al.
Published: (2015-06-01)

Potential renoprotective effects and possible underlying mechanisms of angiotensin receptor-neprilysin inhibitors in cardiorenal syndrome
by: Md. Moshiur Rahman, et al.
Published: (2025-01-01)

POLYMORPHISM OF GENES OF IMMUNOSUPRESSIVE CYTOKINE IL-10 AND TGF-β AT TUBERCULOSIS INFECTION
by: Ye. G. Churina, et al.
Published: (2014-10-01)

MEDICAMENTAL IMMUNOSUPRESSION IN EARLY AGE PEDIATRIC LIVER RECIPIENTS
by: S. V. Gautier, et al.
Published: (2012-09-01)

FACTORS AND MECHANISMS OF IMMUNOSUPRESSION IN EPSTEIN-BARR VIRUS INFECTION
by: L. U. Barycheva, et al.
Published: (2015-08-01)

NEPHROTIC SYNDROME
by: A.N. Tsygin, et al.
Published: (2006-12-01)

Renal Kallikrein Activation and Renoprotection after Dual Blockade of Renin-Angiotensin System in Diet-Induced Diabetic Nephropathy
by: Xia Zou, et al.
Published: (2015-01-01)

Effect of insertion/deletion polymorphism of angiotensin-converting enzyme gene on efficacy of antihypertensive therapy with angiotensin II receptor blockers
by: E. V. Rebrova, et al.
Published: (2024-01-01)

The Fetal Safety of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers
by: Myla E. Moretti, et al.
Published: (2012-01-01)

Are the angiotensin-converting enzime gene and acticity risk factors for stroke? São fatores de risco para acidente vascular cerebral o gene e a atividade da enzima conversora de angiotensina ?
by: Miris Dikmen, et al.
Published: (2006-06-01)

I/D POLYMORPHISM OF ANGIOTENSINE CONVERTING ENZYME IN CHD PATIENTS OF DIFFERENT AGE AND GENDER
by: T. Yu. Rebrova, et al.
Published: (2014-10-01)

Immunosupression with corticosteroids and thymectomy in myastenia gravis: an evaluation of immediate and short term results in 20 patients
by: J. Lamartine de Assis, et al.
Published: (1985-03-01)

Infectious encephalitis diagnosis and treatment in immunosupressed patients: a case report and review of literature
by: M. Jokubaitis, et al.
Published: (2019-06-01)

Debatable points of using angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists in patients with COVID-19
by: O. M. Drapkina, et al.
Published: (2020-07-01)

CARDIOPROTECTIVE AND NEPHROPROTECTIVE EFFECTS OF ANGIOTENSIN CONVERTING ENZYME INHIBITOR RAMIPRIL
by: D. A. Napalkov, et al.
Published: (2016-01-01)

INFLUENCE OF THE POLYMORPHISM OF THE RENIN-ANGIOTENSIN SYSTEM GENES ON THE CARDIAC ARRHYTHMIAS IN CHILDREN WITH HYPERTROPHIC CARDIOMYOPATHY
by: N. A. Berezneva, et al.
Published: (2013-05-01)

POLYMORPHISM OF THE GENE OF β2-ADRENERGIC RECEPTOR AND EFFICIENCY OF THE BRONCHOLYTIC THERAPY AMONG CHILDREN WITH BRONCHIAL ASTHMA
by: O.N. Bryantseva, et al.
Published: (2007-06-01)

An angiotensin-converting enzyme inhibitor in the combination treatment of rheumatoid arthritis
by: E. B. Komarova, et al.
Published: (2017-09-01)

Angiotensin II type 1 receptor gene polymorphism could influence renoprotective response to losartan treatment in type 1 diabetic patients with high urinary albumin excretion rate
by: Dragović Tamara, et al.
Published: (2010-01-01)

PERINDOPRIL: THE POSSIBILITY OF ANTIHYPERTENSIVE AND RENOPROTECTIVE THERAPY
by: O. V. Dralova, et al.
Published: (2016-01-01)

BETA-BLOCKERS AND RENOPROTECTION: THE POTENTIAL OF CARVEDILOL
by: I. T. Murkamilov, et al.
Published: (2017-07-01)

Targeting interleukin-1 signaling for renoprotection
by: Daria Bogdanova, et al.
Published: (2025-05-01)

Hyperkalemia Associated with Angiotensin Converting Enzyme Inhibitor or Angiotensin Receptor Blockers in Chronic Kidney Disease
by: Yudi Her Oktaviono, et al.
Published: (2020-04-01)

Hyperkalemia Associated with Angiotensin Converting Enzyme Inhibitor or Angiotensin Receptor Blockers in Chronic Kidney Disease
by: Yudi Her Oktaviono, et al.
Published: (2020-04-01)

Onset of Hyperkalemia following the Administration of Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker
by: Hye-Ran Jun, et al.
Published: (2021-01-01)

Angiotensin-Converting Enzyme Inhibition and Parathyroid Hormone Secretion
by: Sarah Zaheer, et al.
Published: (2017-01-01)

The use of angiotensin-converting enzyme inhibitors in general medicine
by: M.L.I. Mashitisho
Published: (2012-08-01)

The association of angiotensin-converting enzyme gene polymorphism with respiratory distress syndrome in premature neonates
by: Dina Abdel Razek-Midan, et al.
Published: (2022-06-01)

HOMOCYSTEINE AND KIDNEY'S FUNCTIONAL STATUS OF THE CHILDREN WITH THE NEPHROTIC SYNDROME
by: L.T. Faizova, et al.
Published: (2008-09-01)

A META-ANALYSIS REPORTING EFFECTS OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS IN PATIENTSWITHOUT HEART FAILURE
by: G. Savarese, et al.
Published: (2015-09-01)

A CASE OF DEVELOPMENT OF EXTRACAPILLAR SCHONLEIN–HENOCH NEPHRITIS IN 8-YEARS-OLD CHILD WITH IGA-NEPHROPATHY AND NEPHROTIC SYNDROME
by: N.N. Kartamysheva, et al.
Published: (2009-10-01)

Is there a difference between an angiotensin-converting enzyme inhibitor and an angiotensin-specific receptor blocker for the treatment of hypertension?
by: James A. Ker
Published: (2015-05-01)

Smoking and Angiotensin-converting Enzyme Inhibitor/Angiotensin Receptor Blocker Cessation to Limit Coronavirus Disease 2019
by: Marco Rossato, et al.
Published: (2020-07-01)

The Effect of Angiotensin-Converting Enzyme Gene Polymorphism and Angiotensin II Levels in Coronary Slow Flow Phenomenon at Mohammad Hoesin General Hospital Palembang
by: Arlis Karlina, et al.
Published: (2021-06-01)